In fact, OPG treatment in mice decreased bone resorption and, importantly, significantly reduced tumor area and overall cancer-associated sclerotic bone lesion area after intra-tibial implantation of human breast cancer cells (Zheng et al., 2008). This evidence concerns the gene TNFRSF11B and cancer.